Skip to main content

Table 1 Enrolled participants characteristics

From: Pre-treatment minority HIV-1 drug resistance mutations and long term virological outcomes: is prediction possible?

Participants (n = 78)

Gender

 Males (%)

26 (33.3)

 Females (%)

52 (66.7)

Age (years)

 Range

23–69

 Mean age

35

Baseline CD4 counts (cells/μl)

 

  < 200

39

 200–349

34

  ≥ 350

5

 Mean CD4 count

192

Travel history/Stay outside South Africa

 None

56

 Central Africa

2

 North Africa

1

 Southern Africa

28

 West Africa

2

 Europe

3

Years since HIV diagnosis

  < 1

61

 1–5

15

  > 5

2

Back to article page

Virology Journal

ISSN: 1743-422X